As of 4 Nov 2026, Desh Rakshak Aushdhalaya trades at 25.3× trailing earnings, and the shares are 48% below their 52-week high. It earns ROCE of 5.8% and ROE of 4.8%, and sales and net profit grew 4.8% and 11% a year over 3 years. Debt is 0.24× equity. It is a small-cap company with a market cap of ₹14 Cr; the shares fell 35% over the past year.
- ₹24.50
- ₹24.50
- ₹24.50
- ₹24.50
- 100
Health check
- ReturnsWeak
−34.8% over the past year.
- Price tagNo peers
P/E 25.3, with no peers to compare.
- GrowthSteady
Sales +4.8%, profit +11.5% a year over 3 years.
- ProfitabilityWeak
ROCE 5.8%.
- Balance sheetFair
Debt 0.24× equity, interest covered 5.0×.
- Red flags4 to check
Return on equity is low at 4.8%.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹14 Cr
- Small cap
- P/E
- 25.3
- Price to book
- 1.05
- Book value ₹23.43
- Dividend yield
- 0.00%
- ROE
- 4.8%
- Return on equity
- ROCE
- 5.8%
- Return on capital employed
- Debt to equity
- 0.24
- Debt ₹3.24 Cr
- EPS (TTM)
- ₹0.97
- OPM (TTM)
- 20.9%
- Net margin 8.2%
- Sales growth
- −36.3%
- Latest quarter vs a year ago
- Profit growth
- −16.3%
- Latest quarter vs a year ago
- Price to sales
- 2.10
- EV/EBITDA 12.5
Strengths and risks
Risks to check
- Return on equity is low at 4.8%.
- Quarterly profit down 16.3% on a year ago.
- Quarterly sales down 36.3% on a year ago.
- 48% below its 52-week high.
About Desh Rakshak Aushdhalaya
Desh Rakshak Aushdhalaya Limited manufactures and sells ayurvedic and herbal products in India. It manufactures and processes ayurvedic medicines, ayurvedic composite drug kits, dye kits, and CHW kits. The company also provides medicines in capsules, syrups, granules, tablets, pills, and churana/kwath. It also exports its products. The company was founded in 1901 and is headquartered in Haridwar, India.
- Headquarters
- Haridwar
- Employees
- 18
- Sector
- Healthcare
- ISIN
- INE971E01016
- Website
- deshrakshak.in
Price range
- Avg volume (3M)
- 20
- 1-year return
- minus 34.8%
- From 52-week high
- minus 48.5%
Peers
We couldn’t find listed peers for this company.
Quarterly results
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 |
|---|---|---|---|---|---|
| 1.3 | 1 | 1.4 | 3.5 | 0.8 | |
| 1 | 0.7 | 1.1 | 2.8 | 0.6 | |
| 0.3 | 0.3 | 0.3 | 0.6 | 0.2 | |
| 19.3% | 27.7% | 18.2% | 18.0% | 29.4% | |
| 0 | 0 | 0 | 0 | 0 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| 0.1 | 0.1 | 0.1 | 0.4 | 0.1 | |
| – | – | – | 27.7% | – | |
| 0.1 | 0.1 | 0.1 | 0.3 | 0.1 | |
| 0.22 | 0.15 | 0.16 | 0.52 | 0.14 |
Profit & loss
- Sales CAGR 3Y
- +4.8%
- Profit CAGR 3Y
- +11.5%
- EPS CAGR 3Y
- +93.9%
- ROE
- 4.8%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 6.2 | 6 | 6.3 | 7.1 | |
| – | minus 2.8% | +4.4% | +13.3% | |
| 4.8 | 4.7 | 5 | 5.7 | |
| 1.4 | 1.3 | 1.3 | 1.4 | |
| 22.6% | 21.9% | 20.1% | 19.6% | |
| −0 | −0 | 0 | 0.3 | |
| 0.4 | 0.4 | 0.3 | 0.3 | |
| 0.4 | 0.4 | 0.4 | 0.4 | |
| −0.1 | −0 | – | −0.3 | |
| 0.5 | 0.5 | 0.6 | 0.7 | |
| 15.6% | 15.6% | 15.6% | 16.7% | |
| 0.4 | 0.4 | 0.5 | 0.6 | |
| – | +5.4% | +11.5% | +17.9% | |
| 0.14 | 0.96 | 1.07 | 0.99 |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 4.7 | 4.7 | 4.7 | 5.9 | |
| 4.5 | 4.8 | 5.3 | 7.4 | |
| 4.2 | 2.8 | 3.1 | 3.2 | |
| 2.4 | 4 | 4.9 | 4.4 | |
| 15.7 | 16.3 | 18 | 20.9 | |
| 10.4 | 10 | 9.7 | 9.6 | |
| 6.1 | 2.4 | 1.9 | 1.4 | |
| 0.1 | 0.1 | 0.1 | 0.1 | |
| 0.1 | 0.1 | 0.1 | 0.1 | |
| −0.9 | 3.7 | 6.3 | 9.7 | |
| 15.7 | 16.3 | 18 | 20.9 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 0.5 | 1.5 | −0.3 | −1.3 | |
| −0.8 | −0.1 | −0 | −1.6 | |
| 0.1 | −1.3 | 0.2 | 3 | |
| −0.2 | 0.1 | −0.1 | 0.1 | |
| −0.8 | −0.1 | −0.6 | −1.5 | |
| −0.4 | 1.5 | −0.9 | −2.8 |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.